SMACCForce: Catharsis by Ashley Liebig
SMACCForce: Catharsis by Ashley Liebig
-
Peter Brindley interrogates: Reuben Strayer
Phoebe Adams, , 2017, The Talks DASsmacc, bellomo, brindley, crowe, interrogates, machado, strayer, weingart, 0
A no-holes barred series of 6 provocative medical interrogations. We challenge the state of research, social media, pharmacology, social...
-
Peter Brindley interrogates: Liz Crowe: Love, Swearing and Resilience
Phoebe Adams, , The Talks DASsmacc, interrogation, Love, Resilience, swearing, 0
A no-holds barred series of 6 provocative medical interrogations. We challenge the state of research, social media, pharmacology, social...
-
Did Nietzsche Know Anything About Critical Illness Survivors? by Margaret Herridge
Phoebe Adams, , The Talks DASsmacc, Critical Illness Survivors, Nietzsche, 0
Traditionally, the focus of critical care has simply been on keeping patients alive. This is not enough, now we...
-
Two New York Docs in the Resus Room with Reuben Strayer & Scott Weingart
Phoebe Adams, , The Talks DASsmacc, New York City, Resuscitation, 0
What is New York City style resuscitation? Reuben Strayer and Scott Weingart honed their chops in public hospitals in...
-
16 Bits of Anaphylaxis by Daniel Cabrera
Phoebe Adams, , The Talks DASsmacc, Anaphylaxis, 0
Anaphylaxis is a relatively common and potentially lethal emergency. Current definitions highlight the presence of allergic and allergic-like reactions...
-
SMACCForce: Bariatric Panel Discussion
Phoebe Adams, , 2017, SMACCForce 2017, The Talks DASsmacc, Bariatric, 0
SMACCForce: Bariatric Panel Discussion with Mark Forrest, Jason Van Der Velde, Phil Keating, Cameron O’Leary
-
Neuro EM: Neuroimaging Nibble CTP mismatch in Acute Ischemic Stroke
Phoebe Adams, , The Talks DASsmacc, NeuroImaging, 0
Neuroimaging Nibble: CTP mismatch in Acute Ischemic Stroke by Ronan O’Leary
-
Peter Brindley interrogates: Rinaldo Bellomo
Phoebe Adams, , 2017, The Talks DASsmacc, Kidneys, trials, 0
A no-holes barred series of 6 provocative medical interrogations. We challenge the state of research, social media, pharmacology, social...